The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

Conditions:   Migraine;   Migraine Without Aura;   Migraine With Aura Interventions:   Drug: Erenumab;   Drug: Placebo;   Drug: Calcitonin gene-related peptide;   Drug: Cilostazol Sponsors:   Danish Headache Center;   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials